PPARG and Insulin resistance: The gene expression of PPARγ and its target genes CD36, LDL in whitefat tissue, and PPARα and its target gene ACO in liver were also elevated in CE-treatedDIO mice indicating that CE may act as a dual activator of PPARγ and PPARαresulting in improved insulin resistance and lowered serum lipids.